U.S. Markets closed
  • S&P Futures

    3,585.25
    -16.25 (-0.45%)
     
  • Dow Futures

    28,733.00
    -68.00 (-0.24%)
     
  • Nasdaq Futures

    10,947.50
    -88.00 (-0.80%)
     
  • Russell 2000 Futures

    1,663.40
    -6.40 (-0.38%)
     
  • Crude Oil

    82.07
    +2.58 (+3.25%)
     
  • Gold

    1,672.10
    +0.10 (+0.01%)
     
  • Silver

    19.09
    +0.06 (+0.29%)
     
  • EUR/USD

    0.9789
    -0.0012 (-0.1272%)
     
  • 10-Yr Bond

    3.8040
    +0.0570 (+1.52%)
     
  • Vix

    31.62
    -0.22 (-0.69%)
     
  • GBP/USD

    1.1118
    -0.0048 (-0.4292%)
     
  • USD/JPY

    144.8330
    +0.1040 (+0.0719%)
     
  • BTC-USD

    19,044.88
    -263.70 (-1.37%)
     
  • CMC Crypto 200

    431.41
    -12.02 (-2.71%)
     
  • FTSE 100

    6,893.81
    +12.22 (+0.18%)
     
  • Nikkei 225

    25,937.21
    0.00 (0.00%)
     

Why Teladoc Health Was a Sickly Stock Today

·2 min read

It was a hot item in the thick of the coronavirus pandemic, as telehealth solutions became a viable option in a world of shut-ins and office closures. Recent quarterly earnings disappointments compound the feeling among certain investors that the company's best days are behind it. It's important to note, though, that Teladoc still has more than a few believers.